Patients deserve to know exactly what medication they are receiving, understand how it was developed, and have confidence that treatment decisions are grounded in sound science, not marketing claims
Efficacy is on par with injectable semaglutide with up to 1.7% reduction on the highest dose, and change in fasting glucose from -30 to -42mg/dl which is a significant improvement in glycemia
These data suggest that the activation of CREB signals plays an important role in the anti-inflammatory response, with GLP-1R being implicated in this process
Pharmacological targeting of the transcription factor Nrf2 at the basal ganglia provides disease modifying therapy for experimental parkinsonism
Treatment with FOXO4-DRI normalized these metabolic indicators, effectively restoring kidney filtering capacity to levels approaching those of young animals
Our team of registered nurses with ER/OR/ICU experience administers the NAD+ infusions in a professional setting